img

Global Gastro Esophageal Reflux Disease (GERD) Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gastro Esophageal Reflux Disease (GERD) Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Gastro Esophageal Reflux Disease (GERD) Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gastro Esophageal Reflux Disease (GERD) Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gastro Esophageal Reflux Disease (GERD) Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Gastro Esophageal Reflux Disease (GERD) Drug key manufacturers include Pfizer, Novartis AG, GlaxoSmithKline, Merck, Medtronic, The Kroger Co., Aros Pharma, AstraZeneca, Plc. and Addex Therapeutics, etc. Pfizer, Novartis AG, GlaxoSmithKline are top 3 players and held % sales share in total in 2022.
Gastro Esophageal Reflux Disease (GERD) Drug can be divided into H2 Receptor Antagonist, Proton Pump Inhibitor (PPi) and Antacids,, etc. H2 Receptor Antagonist is the mainstream product in the market, accounting for % sales share globally in 2022.
Gastro Esophageal Reflux Disease (GERD) Drug is widely used in various fields, such as Hospital, Clinic, Medical Center and Others, etc. Hospital provides greatest supports to the Gastro Esophageal Reflux Disease (GERD) Drug industry development. In 2022, global % sales of Gastro Esophageal Reflux Disease (GERD) Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gastro Esophageal Reflux Disease (GERD) Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Novartis AG
GlaxoSmithKline
Merck
Medtronic
The Kroger Co.
Aros Pharma
AstraZeneca, Plc.
Addex Therapeutics
Takeda Pharmaceutical Company Limited
Segment by Type
H2 Receptor Antagonist
Proton Pump Inhibitor (PPi)
Antacids

Segment by Application


Hospital
Clinic
Medical Center
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Gastro Esophageal Reflux Disease (GERD) Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Gastro Esophageal Reflux Disease (GERD) Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Gastro Esophageal Reflux Disease (GERD) Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Gastro Esophageal Reflux Disease (GERD) Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Gastro Esophageal Reflux Disease (GERD) Drug introduction, etc. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Gastro Esophageal Reflux Disease (GERD) Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Gastro Esophageal Reflux Disease (GERD) Drug Market Overview
1.1 Gastro Esophageal Reflux Disease (GERD) Drug Product Overview
1.2 Gastro Esophageal Reflux Disease (GERD) Drug Market Segment by Type
1.2.1 H2 Receptor Antagonist
1.2.2 Proton Pump Inhibitor (PPi)
1.2.3 Antacids
1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type
1.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Type (2018-2024)
2 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Competition by Company
2.1 Global Top Players by Gastro Esophageal Reflux Disease (GERD) Drug Sales (2018-2024)
2.2 Global Top Players by Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2018-2024)
2.3 Global Top Players by Gastro Esophageal Reflux Disease (GERD) Drug Price (2018-2024)
2.4 Global Top Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gastro Esophageal Reflux Disease (GERD) Drug Market Competitive Situation and Trends
2.5.1 Gastro Esophageal Reflux Disease (GERD) Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastro Esophageal Reflux Disease (GERD) Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Gastro Esophageal Reflux Disease (GERD) Drug Market
2.8 Key Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gastro Esophageal Reflux Disease (GERD) Drug Status and Outlook by Region
3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Size by Region
3.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Region (2018-2024)
3.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Market Size by Region
3.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Region (2024-2034)
3.3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Gastro Esophageal Reflux Disease (GERD) Drug by Application
4.1 Gastro Esophageal Reflux Disease (GERD) Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Medical Center
4.1.4 Others
4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application
4.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Breakdown by Application (2018-2024)
5 North America Gastro Esophageal Reflux Disease (GERD) Drug by Country
5.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Size by Country
5.1.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Country (2018-2024)
5.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Market Size by Country
5.2.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Country (2024-2034)
6 Europe Gastro Esophageal Reflux Disease (GERD) Drug by Country
6.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Size by Country
6.1.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Country (2018-2024)
6.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Market Size by Country
6.2.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug by Region
7.1 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Size by Region
7.1.1 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Region (2024-2034)
8 Latin America Gastro Esophageal Reflux Disease (GERD) Drug by Country
8.1 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Size by Country
8.1.1 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Country (2018-2024)
8.2 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Market Size by Country
8.2.1 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug by Country
9.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Size by Country
9.1.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Company Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
10.2.5 Novartis AG Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
10.4.5 Merck Recent Development
10.5 Medtronic
10.5.1 Medtronic Company Information
10.5.2 Medtronic Introduction and Business Overview
10.5.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
10.5.5 Medtronic Recent Development
10.6 The Kroger Co.
10.6.1 The Kroger Co. Company Information
10.6.2 The Kroger Co. Introduction and Business Overview
10.6.3 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
10.6.5 The Kroger Co. Recent Development
10.7 Aros Pharma
10.7.1 Aros Pharma Company Information
10.7.2 Aros Pharma Introduction and Business Overview
10.7.3 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
10.7.5 Aros Pharma Recent Development
10.8 AstraZeneca, Plc.
10.8.1 AstraZeneca, Plc. Company Information
10.8.2 AstraZeneca, Plc. Introduction and Business Overview
10.8.3 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
10.8.5 AstraZeneca, Plc. Recent Development
10.9 Addex Therapeutics
10.9.1 Addex Therapeutics Company Information
10.9.2 Addex Therapeutics Introduction and Business Overview
10.9.3 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
10.9.5 Addex Therapeutics Recent Development
10.10 Takeda Pharmaceutical Company Limited
10.10.1 Takeda Pharmaceutical Company Limited Company Information
10.10.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
10.10.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
10.10.5 Takeda Pharmaceutical Company Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gastro Esophageal Reflux Disease (GERD) Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gastro Esophageal Reflux Disease (GERD) Drug Industrial Chain Analysis
11.4 Gastro Esophageal Reflux Disease (GERD) Drug Market Dynamics
11.4.1 Gastro Esophageal Reflux Disease (GERD) Drug Industry Trends
11.4.2 Gastro Esophageal Reflux Disease (GERD) Drug Market Drivers
11.4.3 Gastro Esophageal Reflux Disease (GERD) Drug Market Challenges
11.4.4 Gastro Esophageal Reflux Disease (GERD) Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors
12.3 Gastro Esophageal Reflux Disease (GERD) Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of H2 Receptor Antagonist
Table 2. Major Company of Proton Pump Inhibitor (PPi)
Table 3. Major Company of Antacids
Table 4. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2018-2024) & (K Pcs)
Table 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share in Value by Type (2018-2024)
Table 9. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2018-2024) & (USD/Pcs)
Table 10. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2024-2034) & (K Pcs)
Table 11. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type (2024-2034)
Table 14. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2024-2034) & (USD/Pcs)
Table 15. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2018-2024) & (K Pcs)
Table 16. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2018-2024)
Table 18. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2018-2024)
Table 20. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Company (2018-2024) & (K Pcs)
Table 26. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Company (2018-2024)
Table 27. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Gastro Esophageal Reflux Disease (GERD) Drug Price by Company (2018-2024) & (USD/Pcs)
Table 30. Global Gastro Esophageal Reflux Disease (GERD) Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastro Esophageal Reflux Disease (GERD) Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Gastro Esophageal Reflux Disease (GERD) Drug Market
Table 34. Key Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2018-2024) & (K Pcs)
Table 38. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 42. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2024-2034) & (K Pcs)
Table 43. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Region (2024-2034)
Table 46. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 47. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2024) & (K Pcs)
Table 49. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2018-2024) & (USD/Pcs)
Table 53. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2024-2034) & (K Pcs)
Table 54. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application (2024-2034)
Table 57. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2024-2034) & (USD/Pcs)
Table 58. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2024) (K Pcs)
Table 59. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2024) (K Pcs)
Table 61. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2024) (K Pcs)
Table 63. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2018-2024) & (K Pcs)
Table 69. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2024-2034) & (K Pcs)
Table 73. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2018-2024) & (K Pcs)
Table 77. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2024-2034) & (K Pcs)
Table 81. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2018-2024) & (K Pcs)
Table 85. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2024-2034) & (K Pcs)
Table 89. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2018-2024) & (K Pcs)
Table 93. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2024-2034) & (K Pcs)
Table 97. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2018-2024) & (K Pcs)
Table 101. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2024-2034) & (K Pcs)
Table 105. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Country (2024-2034)
Table 108. Pfizer Company Information
Table 109. Pfizer Introduction and Business Overview
Table 110. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 111. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 112. Pfizer Recent Development
Table 113. Novartis AG Company Information
Table 114. Novartis AG Introduction and Business Overview
Table 115. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 116. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 117. Novartis AG Recent Development
Table 118. GlaxoSmithKline Company Information
Table 119. GlaxoSmithKline Introduction and Business Overview
Table 120. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 121. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 122. GlaxoSmithKline Recent Development
Table 123. Merck Company Information
Table 124. Merck Introduction and Business Overview
Table 125. Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 126. Merck Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 127. Merck Recent Development
Table 128. Medtronic Company Information
Table 129. Medtronic Introduction and Business Overview
Table 130. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 131. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 132. Medtronic Recent Development
Table 133. The Kroger Co. Company Information
Table 134. The Kroger Co. Introduction and Business Overview
Table 135. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 136. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 137. The Kroger Co. Recent Development
Table 138. Aros Pharma Company Information
Table 139. Aros Pharma Introduction and Business Overview
Table 140. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 141. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 142. Aros Pharma Recent Development
Table 143. AstraZeneca, Plc. Company Information
Table 144. AstraZeneca, Plc. Introduction and Business Overview
Table 145. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 146. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 147. AstraZeneca, Plc. Recent Development
Table 148. Addex Therapeutics Company Information
Table 149. Addex Therapeutics Introduction and Business Overview
Table 150. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 151. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 152. Addex Therapeutics Recent Development
Table 153. Takeda Pharmaceutical Company Limited Company Information
Table 154. Takeda Pharmaceutical Company Limited Introduction and Business Overview
Table 155. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 156. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 157. Takeda Pharmaceutical Company Limited Recent Development
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Gastro Esophageal Reflux Disease (GERD) Drug Market Trends
Table 161. Gastro Esophageal Reflux Disease (GERD) Drug Market Drivers
Table 162. Gastro Esophageal Reflux Disease (GERD) Drug Market Challenges
Table 163. Gastro Esophageal Reflux Disease (GERD) Drug Market Restraints
Table 164. Gastro Esophageal Reflux Disease (GERD) Drug Distributors List
Table 165. Gastro Esophageal Reflux Disease (GERD) Drug Downstream Customers
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastro Esophageal Reflux Disease (GERD) Drug Product Picture
Figure 2. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of H2 Receptor Antagonist
Figure 6. Global H2 Receptor Antagonist Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Proton Pump Inhibitor (PPi)
Figure 8. Global Proton Pump Inhibitor (PPi) Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Antacids
Figure 10. Global Antacids Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type in 2022 & 2034
Figure 13. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Gastro Esophageal Reflux Disease (GERD) Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Gastro Esophageal Reflux Disease (GERD) Drug Revenue in 2022
Figure 25. Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 28. Product Picture of Clinic
Figure 29. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Medical Center
Figure 31. Global Medical Center Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Cost Structure
Figure 47. Gastro Esophageal Reflux Disease (GERD) Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries